HCW Biologics Inc. reported that on May 21, 2025, Armistice Capital exercised its pre-funded warrants, resulting in the issuance of 126,000 shares. Armistice still holds warrants for 210,000 shares, with a previous exercise occurring on May 15, 2025, for 177,140 shares.